Introduction
growth hormone in plasma are found between 2 and 6 h following intramuscular injection of 10 mg HGH Data on tLe serum or plasma concentrations of human in normal adults. Concentrations in plasma returned growth hormone (HGH) following an intramuscular to basal levels between 12 and 24 h after injection. This injection are limited, and blood levels following a dosage is greater than the usual therapeutic range, and therapeutic dose of HGH have not beenstudied system-the observed levels may have been influenced by endoaticall~. PARKER et al. [13] , using a radioimmunoassay genous growth hormone secretion during the period of method, have shown that peak concentrations of observation.
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The present study investigated the levels of growth hormone in plasma following an intramuscular injection of HGH at a therapeutic dose in six patients deficient in growth hormone. A preliminary report of this study has been published [5] .
Material and Methods
Concentrations of growth hormone in plasma, following the initial intramuscular injection of HGH, were determined in six patients with growth hormone deficiency. The clinical diagnosis was based in each patient by evident failure to increase the plasma concentration of growth hormone in response to insulin-induced hypoglycemia, as previously described [4] . Additionally, each patient had subsequently shown a significant response to the long-term administration of HGH. Patients were clinically and chemically euthyroid at the time of HGH administration.
Each patient was fasted overnight prior to challenge. At the time of testing, a needle was inserted into an antecubital vein and was left in place for the next 48 h; a dilute heparin solution maintained patency. Immediately after obtaining a zero-time blood sample, 1 or 2 mg HGH were injected into the gluteal muscle.
The growth hormone preparation used in these studies was National Pituitary Lot no. S-4 [19] , which has a biological potency of 1.54 IU/mg (95% confidence limits 1.03-2.31 IU/mg). The dose of HGH administered to study patients varied from 25 to 60 pglkg body weight (38-92 mIU/kg body weight) (table I). Patients were subsequently allowed to have a regular hospital diet and normal activity. Blood was obtained at 1 5 a n d 3 0 m i n a n d 1 , 2 , 4 , 6 , 8 , 10, 12,24,36and 48 h after HGH administration. Plasma was separated by centrifugation and stored at -20' until assayed. The concentration of growth hormone was measured by a radioimmunoassay method [4, 71, using a highly purified Wilhelmi HGH preparation (no. HS 840 FA) [20] as the standard. An attempt was also made to determine the quantity of growth hormone excreted in the urine by two patients following an intramuscular injection of HGH. Urine was collected a t hourly intervals for the first 2 h, at 2-h intervals for the next 10 h, and at 6-h intervals thereafter for 24 h. An aliquot from each collection was stored at -20' until assayed. The radioimmunoassay method was applied to unextracted urine. In three preliminary experiments HGH [20] , at a concentration of 50 ng/ml, was added to urine obtained from a hypophysectomized patient. Serial dilutions of this urine were assayed in duplicate. The resulting curves paralleled the assay standard curves in each experiment. Mean recovery of added growth hormone was 81 %. The sensitivity of the radioimmunoassay as applied to urine was 0.2 ng growth hormone/ml; this assay will detect 1 ng growth hormone/ml in urine assayed at a dilution of 1 : 5. Unknown urine samples were assayed in duplicate at three dilutions (1 : 5, 1 : 10, and 1 : 20). Nonspecific inhibition of antibody binding of HGH-1311, which could be interpreted erroneously as a result of the presence of growth hormone, was not observed in the assay of urine from a hypophysectomized patient or in 19 unknown urine samples.
Results
The plasma concentrations of growth hormone following a single intramuscular injection are shown in table I1 and fig. 1 . Plasma growth hormone was undetected after an overnight fast in the five patients from whom a sample was available; however, 15 min after the administration of HGH, plasma growth hormone concentrations ranged between 5.2 and 29 ng/ml. Growth hormone levels in plasma rose rapidly to peak concentrations of between 65 and 154 ng/ml ( The mean concentration is shown by closed circles, and & 1 SEM is enclosed in brackets.
Plasma growth hormone concentration after injection 116.4 nglml SEM). At 12 h, the levels had fallen to basal values in three patients, and at 24 and 48 h growth hormone was not detected. The maximum plasma concentration observed during this time was 2.7 ng/ml (table 11) . Growth hormone was not detected in any urine samples obtained following HGH administration. Since the assay will detect 1 ng growth hormone/ml of urine when assayed at a dilution of 1 : 5, the maximum possible concentration of growth hormone in each sample can be calculated from the volume of urine obtained over the period of sampling. The 24-h excretion of growth hormone in urine was less than 3.75 pg in patient RS, and the 12-h excretion was less than 7.5 pg in patient JG. Thus, following injection in these patients, excretion of growth hormone in the urine was less than 0.42 % of the injected dose over 24 h and less than 0.36% over 12 h, respectively.
Discussion
HUNTER and RIGAL [I 11 have investigated the normal diurnal variation in plasma concentration of growth hormone in children and adolescents. In these studies, the plasma concentration showed a pattern of postprandial peaks during the day and spontaneous peaks during the night. The concentration in plasma was generally lower than 20 nglml, and in only one subject reached the level of 50 ng/ml during a 24-h period. The pattern of plasma concentrations observed after a single intramuscular injection was markedly different from the reported normal diurnal pattern. For six hours after HGH was injected (1 or 2 mg), the plasma concentrations were in the range usually found in acromegaly [I, 8, 91 .
The applicability of the radioimmunoassay technique to the measurement of growth hormone in urine is controversial. Using this method, normal values reported for the amount of growth hormone excreted in urine varied considerably among laboratories [2, 12, 161 . A recent paper [6] suggests that substances that inhibit binding of tracer growth hormone and antibody are present in normal urine. Nonspecific inhibition of the radioimmunoassay system, not demonstrated in the present study, would give erroneously high values for urinary growth hormone.
The absence of detectable growth hormone in urine following an intramuscular injection of HGH confirms the findings of NAJJAR and BLIZZARD [12] . They administered 5 or 10 mg HGH to hypopituitary patients and detected 0.1-0.3% of the injected dose in subsequent 24-h urine collections. The rapid disappearance of growth hormone from plasma following a single injection, and the absence of the injected dose in the
urine, suggest rapid intracellular distribution of hormone. Another possible explanation for this disappearance is an alteration of administered growth hormone by proteolytic enzymes in plasma, which would alter the immunoreactivity of HGH and produce substances that, while active in promoting linear growth, are not detected by radioimmunoassay.
Human growth hormone injected at biweekly or triweekly intervals promoted linear growth in hypopituitary patients [lo, 14, 171, and one report [15] suggested that weekly injections are also effective. Our observations indicated that HGH was detectable at significant concentrations in the plasma of hypopituitary patients for a maximum of 24 h following a single intramuscular injection. This finding and the results of investigative HGH therapy suggest that growth hormone has an effect on the intracellular protein synthesis that persists after the disappearance of growth hormone from the circulation. The observation of FLORINI and BREUER [3] that increased RNA polymerase activity in the rat reaches a peak in skeletal muscle 18 h after the injection of growth hormone supports this hypothesis. Increased protein synthetic activity of muscle ribosomes persists for 48 h after the injection.
Summary
Plasma concentrations of growth hormone following a single intramuscular injection of HGH were measured in six patients deficient in growth hormone. Growth hormone was detected in plasma 15 min after injection, and levels usually found in acromegaly were observed for 6-8 h after injection. Plasma levels returned to control values 24 h after HGH administration, but the pattern is markedly different from the normal diurnal variation of growth hormone concentration in plasma. Growth hormone was not detected in urine after an intramuscular injection of HGH.
